SEC Form 4 · accession 0000899243-17-029000
Acer Therapeutics Inc. · ACER
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steve Aselage
Director
Period of report
Dec 14, 2017
Accepted (ET)
Dec 18, 2017 · 4:01 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001069308
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 14, 2017 | P | 2,000 | $12.00 | A | 13,905 | D |
Table II — derivative securities
No Table II lines on this filing.